Replies to post #1449 on Precious Metals

[gfp927z]

Blade, >> CRDF <<


Thanks. I replaced LIFE with CRDF on the list. It's great having a knowledgeable guy like you around :o)

It's going to take a while to get even moderately up to speed on these stocks. Bio is the hardest sector there is, and no matter how much research one does, it never seems to be enough.

For stock exposure, I mostly am using broad index ETFs, and sector ETFs have largely replaced the role that individual stocks once played in the portfolio. Still, it's nice to have some promising stocks to follow. I use strict position limits, so you don't have to worry about me misusing your stock ideas to 'bet the farm' :o)

[gfp927z]

Blade, Any thoughts on MGTA? The stock has had a good move in the last several months. I'm not up on the stem cell area, but looks like some advanced science. I remember you had mentioned MGTA a while back -


>>> Magenta Therapeutics, Inc. (MGTA), a clinical-stage biotechnology company, develops novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100, C200, and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a novel stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an antibody-drug conjugate program to prevent acute graft and host diseases. It has a has a research and clinical collaboration agreement with AVROBIO, Inc.to evaluate targeted antibody-drug conjugate as a conditioning regimen for lentiviral gene therapies; and clinical trial collaboration with bluebird bio, Inc. to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts. <<<